Filippo Mulinacci
Chief Business Officer Araris Biotech AG
Dr. Filippo Mulinacci, MBA is Chief Business Officer at Araris Biotech AG, a wholly owned subsidiary of Taiho Pharmaceutical, leading business development and licensing strategy for the company’s ADC platforms. He brings over a decade of transactional experience in oncology and technology partnering. Previously, he was Oncology BD&L Manager at Basilea and spent nearly five years at Roche in global business development, identifying novel assets and negotiating collaborations across multiple therapeutic areas. Filippo began his career in research, holding positions at Merck-Serono where he focused on protein biochemistry and preformulation. He holds a MSc in Chemistry from the University of Turin, Italy, and a PhD in Pharmaceutical Sciences from the University of Geneva, Switzerland.
